StonvexLoading…
StonvexStonvexStonvexCore line items from TMO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $44.56B | $42.88B | $42.86B | $44.91B |
Operating Income | $7.75B | $7.34B | $6.86B | $8.39B |
Net Income | $6.70B | $6.33B | $6.00B | $6.96B |
EPS (Diluted) | $17.74 | $16.53 | $15.45 | $17.63 |
Total Assets | $110.34B | $97.32B | $98.73B | $97.15B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.85B | $4.01B | $8.08B | $8.52B |
Free Cash Flow OCF − CapEx | $6.29B | $7.27B | $6.93B | $6.91B |
Shares Outstanding | 378.00M | 383.00M | 388.00M | 394.00M |